Medtronic
MDT
$2.59 (-2.96%)
1D
1W
3M
1Y
5Y
ALL
Medtronic Public Limited Company is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients. The Company has four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Medical Surgical Portfolio, the Neuroscience Portfolio, and the Diabetes Operating Unit. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 10 hours ago • MDT
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs FixingBenzinga • 11 hours ago • MDT
Gold Moves Higher; Medtronic Posts Upbeat ResultsSeeking Alpha • 1 day ago • MDT
Medtronic plc (MDT) Q2 2025 Earnings Call TranscriptZacks Investment Research • 1 day ago • MDT
Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 ViewZacks Investment Research • 1 day ago • MDT
Compared to Estimates, Medtronic (MDT) Q2 Earnings: A Look at Key MetricsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.